Decreased trkA neurotrophin receptor expression in the parietal cortex of patients with Alzheimer's disease

Neuroscience Letters

Volumn 241, Issue 2-3, 1998, Pages 151-154

  Hock, Christoph ^a   Heese, Klaus ^a   Müller Spahn, Franz ^a   Hulette, Christine ^b   Rosenberg, Carlyn ^b   Otten, Uwe ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Basal forebrain; Dementia; Nerve growth factor; Neurodegeneration; Neurotrophin; Reverse transcription polymerase chain reaction

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROTROPHIN; NEUROTROPHIN 3; NEUROTROPHIN 4; NEUROTROPHIN RECEPTOR; TYROSINE KINASE RECEPTOR;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DEMENTIA; FEMALE; FOREBRAIN; HUMAN; HUMAN TISSUE; MALE; NERVE CELL NECROSIS; NERVE DEGENERATION; PARIETAL LOBE; PRIORITY JOURNAL; RECEPTOR AFFINITY; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PARIETAL LOBE; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0032579285     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(98)00019-6     Document Type: Article

References (18)

1. Boissiere F., Faucheux B., Ruberg M., Agid Y., Hirsch E.C. Decreased trkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145(1):1997;245-252.
2. Bothwell M. Functional interactions of neurotrophins and neurotrophin receptors. Ann. Rev. Neurosci. 8:1995;223-253.
3. Chomczynski P., Sacchi N. Single-step method of RNA isolation by guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
4. Connor B., Young D., Lawlor P., Gai W., Waldvogel H., Faull R.L.M., Dragunow M. Trk receptor alterations in Alzheimer's disease. Mol. Brain Res. 42:1996;1-17.
5. Fahnestock M., Scott S.A., Jette N., Weingartner J.A., Crutcher K.A. Nerve growth factor mRNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Mol. Brain Res. 42:1996;175-178.
6. Goedert M., Fine A., Dawbarn D., Wilcock G.K., Chao M.V. Nerve growth factor receptor mRNA distribution in human brain: normal levels in basal forebrain in Alzheimer's disease. Mol. Brain Res. 5:1989;1-7.
7. Hyman C., Hofer M., Barde Y.A., Juhasz M., Yancopoulos G.D., Squinto S.P., Lindsay R.M. BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature. 350:1991;230-232.
8. Knüsel B., Winslow J.W., Rosenthal A., Burton L.E., Seid D.P., Nicolics K., Hefti F. Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc. Natl. Acad. Sci. USA. 88:1991;961-965.
9. Mamounas L.A., Blue M.E., Siuciak J.A., Altar C.A. Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain. J. Neurosci. 15:1995;7929-7939.
10. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 34:1984;939-944.
11. Mirra S.S., Heyman A., McKeel D., Sumi S.M., Crain B.J., Brownlee L.M., Vogel F.S., Hughes J.P., van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathological assessment of Alzheimer's disease. Neurology. 41:1991;479-486.
12. Mufson E.J., Conner J.M., Kordower J.H. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. NeuroReport. 6:1995;1063-1066.
13. Mufson E.J., Li J.M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8(1):1996;25-29.
14. Mufson E.J., Lavine N., Jaffar S., Kordower J.H., Quirion R., Saragovi H.U. Reduction in p140-trkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
15. Narisawa-Saito M., Wakabayashi K., Tsji S., Takahashi H., Nawa H. Regional specificity of alterations in NGF, BDNF and NT-3 levels in Alzheimer's disease. NeuroReport. 7:1996;2925-2928.
16. Salehi A., Verhaagen J., Dijkhuizen P.A., Swaab D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
17. Scott S.A., Mufson E.J., Weingartner J.A., Skau K.A., Crutcher K.A. Nerve growth factor in Alzheimer's disease: increased levels throughout the brain coupled with declines in nucleus basalis. J. Neurosci. 15:1995;6213-6221.
18. Selkoe D.J. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10:1994;373-403.